Trial Profile
A randomised, double blind, parallel group trial of twice daily inhaled fluticasone propionate 100 / salmeterol 50 (Seretide 100) [Seretide] versus placebo in asthma-related cough
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2005
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 25 Jul 2005 New trial record.